See inside every stock. Pro
WatchlistPro
S&P 5007,663▼ 1.21%Nasdaq26,009▼ 2.60%Dow Jones52,868▲ 0.02%Nasdaq 10028,959▼ 2.90%VIX19.03▲ 14.09%US Dollar101.62▼ 0.16%Gold spot4,093▼ 0.80%WTI103.60▲ 4.15%

2x Solana (SOLT)

Leveraged ETF · US-listed · NASDAQ
$56.62 ▼ -5.54 (8.91%)
At close · USD · Volume 331,011
Returns and riskCostIncomeDividend historyHoldingsQuestions
52-week range
$23.28 – $409.30
Day's range
$56.09 – $58.61
1-year total return
−82.3%
Leveraged fund (2x, by its name). The stated multiple applies to one day. It resets daily, so returns over longer periods can differ a lot from the multiple, and the figures below describe the past only.

SOLT price chart

Daily, split-corrected, distributions markedEnd-of-day prices

SOLT fund facts

Fund2x Solana ETF
TickerSOLT · NASDAQ
Issuer (by our rules)–
Category (by our rules)Leveraged
Expense ratioNot in our sources
Holdings–
Net assets (fund, SEC)–
Yield (last 12 months)2.43%
DistributionsMonthly
52-week range$23.28 – $409.30
Average volume (3 months)500,131
First price in our data20 Mar 2025
Issuer and category are assigned by StocksXray rules from the fund name. Expense ratio and net assets come from SEC filings; where a fund does not file them (for example grantor trusts) the field stays empty.

Returns and risk

1 month
−25.4%
3 months
+60.6%
6 months
+14.1%
Year to date
−55.1%
1 year
−82.3%
3 years a year
n/a
5 years a year
n/a
10 years a year
n/a
Volatility (1 year)
142.0%
Largest drop, last year
−93.7%
Largest drop in our data
−96.3%
Total return includes distributions, from end-of-day prices adjusted for splits and distributions, to 22 Oct 2026. Periods of 3 years and longer are annualised and shown only when the fund's history is long enough. Volatility is the standard deviation of daily returns over the last year, annualised. Past performance does not guarantee future results.

Cost: expense ratio

We could not match an expense ratio for SOLT in the SEC prospectus data we read. Funds structured as trusts or notes, and very new funds, are often missing. We show nothing rather than a guess; the issuer's fact sheet has the figure.

Income: distributions

Paid, last 12 months
1.37 USD
Yield on today's price
2.43%
Frequency
Monthly
Latest ex-date
21 Oct 2026
Full SOLT dividend history →
Cash paid per current share (restated for share splits), before tax, from EODHD.

SOLT top holdings

We have no holdings for SOLT. Holdings come from Form N-PORT filed with the SEC; grantor trusts, unit investment trusts and notes do not file it, and we do not guess a portfolio.

Similar Leveraged ETFs

IREZ Tradr 2X Short IREN Daily1.49% fee · – 1y IBX Tradr 2X Long IBM Daily1.30% fee · – 1y DDM ProShares Ultra Dow30+23.2% 1y UWM ProShares Ultra Russell2000+21.0% 1y RKLX Defiance Daily Target 2X Long...1.29% fee · −76.4% 1y JDST Direxion Daily Junior Gold Min...−62.6% 1y All leveraged ETFs →
Funds of the same category, nearest in trading size. Similar does not mean equivalent: check holdings and costs.

SOLT: frequently asked questions

What is SOLT?

SOLT is the 2x Solana ETF, listed on NASDAQ. By our rules it is classed as "Leveraged".

Does SOLT pay dividends?

Yes. SOLT paid 1.37 per share over the last 12 months, monthly, a trailing yield of 2.43% on today's price. The latest ex-dividend date was 21 Oct 2026.

How has SOLT performed?

Total return including distributions to 22 Oct 2026: 1 year −82.3%. Past performance does not guarantee future results.

Is SOLT leveraged?

By its name SOLT aims for 2x the daily return of its target. The multiple resets every day, so returns over weeks or months can differ a lot from the stated multiple, and losses can compound. Funds like this are designed for short holding periods.

Where the numbers come from

Prices and distributions end-of-day data from EODHD; returns are our own calculations from it.
Expense ratio and holdings SEC filings (prospectus risk/return data and Form N-PORT).
Category, issuer and leverage assigned by StocksXray rules from the fund name.
X-Ray look-through our scores applied to the SEC holdings.
Read the methodology →

StocksXray is for education only and is not financial advice or a recommendation to buy or sell anything. Past performance does not guarantee future results; funds can lose value.